RegeneRx Closes $7.3 Million Offering of Common Stock

BETHESDA, Md.—(BUSINESS WIRE)—March 16, 2006—RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN) today closed its previously announced registered direct offering. The company sold 2,591,952 shares of common stock at $2.81 per share for aggregate gross proceeds of $7.3 million.

Source: RegeneRx Biopharmaceuticals, Inc.